2021 IAB Companies and Representatives
908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets.
Representatives: Glenn Harris, Shamali Roy
Agilent Technologies Inc. is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
Representatives: MaryAnn Shen, Linfeng Wu
Biognosys is a leader in next-generation proteomics, dedicated to transforming life science by inventing and developing cutting-edge mass spectrometry technology and solutions and making them widely available for biopharma researchers and proteomics experts. The Company offers a versatile portfolio of proprietary services, software, and kits that provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research.
Representatives: Kristina Beeler, Yuehan Feng
Bruker provides innovative mass spectrometry systems for proteomics that overcome long-standing limitations in speed, sensitivity and robustness. We offer a complete range of proteomics solutions to enhance analytical depth and throughput and to minimize maintenance and downtime.
Representatives: Gary Kruppa, Pierre-Olivier Schmit
Cambridge Isotope Laboratories, Inc. (CIL) is the world leader in the manufacturer of stable isotopes (e.g.,13C, D, 15N) and their compounds for an array of qualitative/quantitative research applications ranging from analytical chemistry to modern diagnostics. Proteomic products include peptide synthesis and protein expression starting materials, SILAC and SILAM reagents/kits, QC and quantitation kits, chemical tagging reagents, and enzymatic labeling reagents. CIL also offers an array of standards and mixes/kits for use in other MS ‘omics research (e.g., metabolomics, glycomics).
Representatives: Joel Louette, Andrew Percy
CellCarta is the leading provider of specialized precision medicine laboratory services with integrated platforms in immunology, histopathology, proteomics, genomics, and related specimen collection and logistics services. CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials, and operates globally with laboratories in Canada, USA, Belgium, Australia, and China.
Representatives: Nicholas Dupuis, Gwenaël Pottiez
EVOSEP aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. Making sample preparation and separation before MS analysis 10 times faster and 100 times more robust will enable truly large cohort studies for biomarker validation and provide the foundation for precision medicine.
Representatives: Michael Andersen, Nicolai Bache
Illumina is an applied genomics technology company making genomics useful for all. We are tirelessly working to create the leading-edge technology that enables clinicians and researchers to not only understand the genome but also fully tap its power. Discoveries that were unimaginable just a few years ago are becoming routine, and we’re just getting started.
Representatives: Jenny Xiao, Fiona Kaper
IonOpticks is revolutionising chromatography with robust and highly reproducible nanoflow columns that are leading the market in spray stability and depth of sample characterisation. Our plug and play zero dead volume packed emitter technology is setting a new standard, achieving over 25% more protein identifications than any other product on the market.
Representatives: Selima Webb, Jarrod Sandow
Newomics Inc. is a commercial stage biotechnology company in the San Francisco bay area. It is dedicated to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. Its products include silicon-based multinozzle emitters (M3 emitters) and microfluidic LC-MS chips (MEA chips) that significantly increase the sensitivity and robustness of mass spectrometry.
Representatives: Yi Zhang, Na Parra
Olink offers unmatched high-multiplex analysis of actionable biomarkers within the human plasma proteome. We provide quantifiable results from minimal sample volume, with high throughput and exceptional sensitivity and specificity. Our mission is to accelerate proteomics together with the scientific community, enabling new discoveries and a better understanding of complex real-time human biology. We are committed to expand our protein library, providing coverage across a growing number of biological processes and pathways.
Representatives: Ida Grundberg, Eva Walde
Pelago Bioscience was founded in 2013 with the aim to maximize the awareness and use of our patented Cellular Thermal Shift Assay (CETSA®). Using CETSA we deliver in situ target engagement studies to accelerate preclinical and clinical drug discovery and diagnostics development. Our scientific team are the experts in both targeted (Classics & HT) and unbiased proteomics CETSA applications (CETSA MS/Thermal Proteome Profiling).
Representatives: Daniel Martinez Molina, Johan Lengqvist
ProtiFi, LLC provides innovative solutions for omics analyses from sample preparation trough to data analysis and is a spin out of Cold Spring Harbor Laboratory. The S-Trap, our sample extraction, concentration and cleaning system, has revolutionized our ability to obtain MS ready samples in record time regardless of sample or skill level. Tryp-N, “N-terminal trypsin,” gives complementary data to increase sequence coverage and certainty of identification. Finally, Simplifi makes it easy and simple to go from huge omics datasets to meaning and understanding of biology.
Representatives: John Wilson, Joanna Kirkpatrick
SCIEX solutions for biomarker & omics research enable scientists to push the limits in discovery proteomics, targeted peptide quantitation, lipidomics, metabolomics, protein characterization, and tissue imaging.
Representatives: Arianna Jones, Alexandra Antonoplis
Seer develops innovative solutions that act as a gateway to the proteome. Our products are designed to accelerate the pace of proteomics by removing the technological barriers that stand between you and the proteomics you want to do. The Proteograph platform enables unbiased, deep, rapid, large-scale proteomics studies – the kind needed to advance our understanding of biology, health, and disease. Our goal is to empower the scientific community with tools for exceptional proteomics outcomes.
Sengenics is a functional proteomics company that leverages its patented KREX technology for production of full-length, correctly folded and functional proteins. KREX was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge.
Representatives: Jonathan Blackburn, Katy McGirr
SomaLogic seeks to deliver meaningful and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from the precise, proprietary, and personalized measurement of health-related changes in an individual’s proteins over time.
Representatives: Sheri Wilcox, Sean Lynch
Thermo Scientific is the leading source of innovative, comprehensive workflow solutions to address the most challenging aspects of proteomics research.
Representatives: Kay Opperman, Daniel Lopez-Ferrer
From biomarker discovery and translational research through to clinical diagnostic solutions, at Waters, we strive to improve human health by partnering with the biomedical community to help make breakthrough scientific discoveries and translate them into healthcare solutions.
Representatives: David Heywood, Roy Martin